Format

Send to

Choose Destination
Mol Cancer Ther. 2008 Sep;7(9):2662-71. doi: 10.1158/1535-7163.MCT-08-0136.

Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism.

Author information

1
Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA. mrettig@mednet.ucla.edu

Erratum in

  • Mol Cancer Ther. 2008 Nov;7(11):3654.

Abstract

Constitutive nuclear factor-kappaB (NF-kappaB) activation is observed in androgen-independent prostate cancer and represents a predictor for biochemical recurrence after radical prostatectomy. Dietary agents such as pomegranate extract (PE) have received increasing attention as potential agents to prevent the onset or progression of many malignancies, including prostate cancer. Here, we show that PE inhibited NF-kappaB and cell viability of prostate cancer cell lines in a dose-dependent fashion in vitro. Importantly, maximal PE-induced apoptosis was dependent on PE-mediated NF-kappaB blockade. In the LAPC4 xenograft model, PE delayed the emergence of LAPC4 androgen-independent xenografts in castrated mice through an inhibition of proliferation and induction of apoptosis. Moreover, the observed increase in NF-kappaB activity during the transition from androgen dependence to androgen independence in the LAPC4 xenograft model was abrogated by PE. Our study represents the first description of PE as a promising dietary agent for the prevention of the emergence of androgen independence that is driven in part by heightened NF-kappaB activity.

PMID:
18790748
PMCID:
PMC2858627
DOI:
10.1158/1535-7163.MCT-08-0136
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center